A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

This study has been withdrawn prior to recruitment.

( Study was cancelled before patient enrollment )

Study NCT00386555 Information provided by Pfizer

First Received: October 6, 2006 Last Updated: June 6, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given